Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis.
Publication/Presentation Date
8-1-2007
Abstract
Extended-spectrum beta-lactamase (ESBL) producing organisms are resistant to penicillins, cephalosporins, aminoglycosides, trimethoprim-sulfamethoxazole, aztreonam, and most fluoroquinolones. We report a case of a 72-year old man who developed septic shock with an ESBL organism after a transrectal ultrasound (TRUS)-guided prostate biopsy despite having received fluoroquinolone prophylaxis. The patient recovered with intravenous ertapenem. Fluoroquinolone resistant bacteria are increasing in prevalence. This needs to be recognized when the antibiotic choice for pre-procedure prophylaxis is made.
Volume
14
Issue
4
First Page
3653
Last Page
3655
ISSN
1195-9479
Published In/Presented At
Cannon, G. M., Jr, Smaldone, M. C., & Paterson, D. L. (2007). Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis. The Canadian journal of urology, 14(4), 3653–3655.
Disciplines
Medicine and Health Sciences
PubMedID
17784990
Department(s)
Department of Surgery
Document Type
Article